ValuEngine upgraded shares of Health Insurance Innovations (NASDAQ:HIIQ) from a buy rating to a strong-buy rating in a research note published on Tuesday.

HIIQ has been the topic of several other reports. Zacks Investment Research lowered shares of Health Insurance Innovations from a hold rating to a sell rating in a report on Wednesday, May 23rd. Canaccord Genuity reissued a buy rating and set a $62.00 price objective (up from $55.00) on shares of Health Insurance Innovations in a report on Thursday, August 2nd. Cantor Fitzgerald reissued a buy rating on shares of Health Insurance Innovations in a report on Friday, June 8th. BidaskClub raised shares of Health Insurance Innovations from a buy rating to a strong-buy rating in a report on Tuesday, June 5th. Finally, B. Riley lifted their price target on shares of Health Insurance Innovations from $45.00 to $56.00 and gave the stock a buy rating in a report on Tuesday, August 7th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Health Insurance Innovations presently has an average rating of Buy and an average target price of $47.07.

Shares of HIIQ stock opened at $52.05 on Tuesday. The company has a market cap of $880.27 million, a P/E ratio of 34.74 and a beta of 0.58. Health Insurance Innovations has a 52-week low of $12.65 and a 52-week high of $57.03.

Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings data on Wednesday, August 1st. The financial services provider reported $0.61 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.03. The company had revenue of $71.70 million for the quarter, compared to analyst estimates of $70.51 million. Health Insurance Innovations had a net margin of 5.39% and a return on equity of 19.43%. Health Insurance Innovations’s revenue was up 16.0% compared to the same quarter last year. During the same period last year, the company posted $0.46 earnings per share. equities analysts predict that Health Insurance Innovations will post 2.06 EPS for the current year.

In other Health Insurance Innovations news, CEO of HealthPocket, Inc. division Bruce Telkamp sold 7,517 shares of Health Insurance Innovations stock in a transaction on Monday, August 6th. The shares were sold at an average price of $43.20, for a total value of $324,734.40. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director John Fichthorn purchased 11,162 shares of the business’s stock in a transaction on Tuesday, June 19th. The stock was purchased at an average cost of $33.95 per share, for a total transaction of $378,949.90. Following the completion of the acquisition, the director now directly owns 7,608 shares of the company’s stock, valued at approximately $258,291.60. The disclosure for this purchase can be found here. Insiders sold 24,110 shares of company stock worth $980,909 over the last ninety days. Corporate insiders own 55.94% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vident Investment Advisory LLC grew its holdings in Health Insurance Innovations by 8.0% in the second quarter. Vident Investment Advisory LLC now owns 18,935 shares of the financial services provider’s stock worth $613,000 after purchasing an additional 1,409 shares during the last quarter. Globeflex Capital L P lifted its stake in shares of Health Insurance Innovations by 14.3% during the second quarter. Globeflex Capital L P now owns 16,000 shares of the financial services provider’s stock worth $518,000 after buying an additional 2,000 shares during the period. Schwab Charles Investment Management Inc. lifted its stake in shares of Health Insurance Innovations by 3.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 61,727 shares of the financial services provider’s stock worth $1,997,000 after buying an additional 2,046 shares during the period. Northern Trust Corp lifted its stake in shares of Health Insurance Innovations by 1.6% during the first quarter. Northern Trust Corp now owns 135,265 shares of the financial services provider’s stock worth $3,909,000 after buying an additional 2,175 shares during the period. Finally, First Trust Advisors LP lifted its stake in shares of Health Insurance Innovations by 20.0% during the second quarter. First Trust Advisors LP now owns 13,905 shares of the financial services provider’s stock worth $450,000 after buying an additional 2,315 shares during the period. 86.90% of the stock is currently owned by institutional investors and hedge funds.

About Health Insurance Innovations

Health Insurance Innovations, Inc operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies.

Featured Article: How Do I Invest in Dividend Stocks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.